Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

Quest Diagnostics (NYSE: DGX) will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026 before market open.

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026 before market open. The company will host a conference call at 8:30 a.m. Eastern Time the same day.

Dial-in details: 888-455-0391 (U.S./Canada) or 773-756-0467 (international) with passcode 7895081. The earnings release and live webcast will be posted at www.QuestDiagnostics.com/investor. Participants are advised to dial in ~10 minutes early.

A replay will be available online at the investor site and by phone at 866-388-5361 (domestic) or 203-369-0416 (international) from ~10:30 a.m. ET on February 10, 2026 until midnight ET on February 24, 2026. Investors are encouraged to review the company’s periodic SEC filings, including risk factors.

Argus Jan 8 session

-0.22% close to close Open Argus

Details

News Market Reaction – DGX

In the Jan 8 session, DGX declined 0.22%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement set February 10, 2026 as the date for Quest Diagnostics’ fourth quarter and full-y...

Analysis

This announcement set February 10, 2026 as the date for Quest Diagnostics’ fourth quarter and full-year 2025 results, with a conference call at 8:30 a.m. ET. It primarily provided logistics, including dial-in numbers, passcode, and replay details, rather than new financial figures. In context of recent collaborations and conference presentations, investors may focus on how upcoming results reflect these strategic moves and any commentary on capital structure given the existing S-3ASR debt shelf.

Key Figures

Earnings release date: February 10, 2026 Conference call time: 8:30 a.m. ET US/Canada dial-in: 888-455-0391 +5 more

Earnings release date

February 10, 2026

Q4 and full-year 2025 results to be reported before market open

Conference call time

8:30 a.m. ET

Start time for Q4/FY 2025 earnings call on February 10, 2026

US/Canada dial-in

888-455-0391

Domestic access number for Q4/FY 2025 earnings call

International dial-in

773-756-0467

International access number for Q4/FY 2025 earnings call

Call passcode

7895081

Passcode required for live earnings conference call

Replay US number

866-388-5361

Domestic telephone replay for earnings call

Replay international

203-369-0416

International telephone replay for earnings call

Replay window

Feb 10–24, 2026

Telephone replay available from ~10:30 a.m. ET Feb 10 to midnight Feb 24

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Clinical data update

   24h Move

   +4.0%

   Haystack MRD ctDNA data highlighted at 2026 ASCO GI symposium.

2. Jan 05

   JV partnership

   24h Move

   -0.2%

   Corewell Health JV forming Diagnostic Lab of Michigan with Quest majority.

3. Dec 19

   Conference appearance

   24h Move

   -0.1%

   Planned presentation at 44th J.P. Morgan Healthcare Conference.

4. Dec 09

   Research collaboration

   24h Move

   -1.2%

   Haystack MRD collaboration in phase II MRD-PORT trial for NSCLC.

5. Dec 01

   Strategic collaboration

   24h Move

   -2.9%

   Octave MSDA Test access via ~7,000 Quest patient service centers.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on February 10, 2026 until midnight Eastern Time on February 24, 2026.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-fourth-quarter-and-full-year-2025-financial-results-on-february-10-2026-302655842.html

SOURCE Quest Diagnostics Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Quest Diagnostics (DGX) report Q4 and full year 2025 results?

Quest Diagnostics will report results on Tuesday, February 10, 2026 before the market opens.

What time is the Quest Diagnostics (DGX) earnings call on February 10, 2026?

The conference call begins at 8:30 a.m. Eastern Time on February 10, 2026.

How can I join the Quest Diagnostics (DGX) Q4 2025 earnings call by phone?

Call 888-455-0391 (U.S./Canada) or 773-756-0467 (international) and use passcode 7895081.

Where will Quest Diagnostics (DGX) post the earnings release and webcast?

The earnings release and live webcast will be posted at www.QuestDiagnostics.com/investor.

How can I access the replay of the Quest Diagnostics (DGX) February 10, 2026 call?

Replay is available online at the investor site or by phone at 866-388-5361 (domestic) or 203-369-0416 (international) from ~10:30 a.m. ET Feb 10 through midnight ET Feb 24, 2026.

Should investors review Quest Diagnostics (DGX) SEC filings before the call?

Yes. Investors are encouraged to read the company’s periodic SEC filings, including risk factors and historical financial information.